The global burden of chronic kidney disease is increasing rapidly in low- and middle-income countries, including Vietnam. Death from chronic kidney disease ranks 8th among the 10 leading causes of death in Vietnam. The number of new cases diagnosed each year is about 8,000.
Death from chronic kidney disease ranks 8th among the 10 leading causes of death in Vietnam
Information at the seminar with the topic “Multi-dimensional perspectives in the application of medical advances in chronic kidney disease management ” organized by the Vietnam Medical Association today September 23, Associate Professor. Dr. Nguyen Thi Xuyen – President of the Vietnam Medical Association said that in reality, the global burden of chronic kidney disease is increasing rapidly and is predicted to become the 5th cause of lost years of life worldwide. world by 2040. It is worth noting that the burden of chronic kidney disease increases faster in low- and middle-income countries, including Vietnam.
Clarifying more about the global situation of chronic kidney disease, Associate Professor, Dr. Nguyen Khoa Dieu Van – Vice President of the Vietnam Endocrine and Diabetes Association emphasized: chronic kidney disease is a silent disease that is increasing in the world. and in Asia, with over 840 million infected people in the world, accounting for 11-13.4% of the population, of which two-thirds of the burden is concentrated in low- and middle-income countries.
“1.2 million people die from chronic kidney disease each year, plus 1.4 million people with cardiovascular disease die due to impaired kidney function, over 2 million people die due to lack of access to dialysis”- Associate Professor, Dr. Nguyen Khoa Dieu Van cited and added: Impaired kidney function leads to a significant increase in the rate of cardiovascular events and death, while also reducing quality of life.
Information at the discussion showed that in Vietnam, it is estimated that more than 10 million people have chronic kidney disease, accounting for 10.1% of the population. Death from chronic kidney disease ranks 8th among the 10 leading causes of death in Vietnam. The number of new cases diagnosed each year is about 8,000.
The number of cases requiring dialysis is about 800,000 patients, but currently Vietnam only has 5,500 machines serving 33,000 patients. According to statistics, 50% of hemodialysis patients die within 5 years, with medical costs for dialysis treatment increasing three times as much as the cost of managing early-stage chronic kidney disease.
However, according to Associate Professor, Dr. Dieu Van, this disease is still not given proper attention “almost when going for a check-up or health check-up, no patient ever tells the doctor to check for kidney disease. This explains why only 4.5 – 15.5% of adults with chronic kidney disease are diagnosed. Usually when discovered, it is already stage 3 or 4.
The rate of chronic kidney disease detected in stage 3 is only 5% of adults
The seminar ” Multi-dimensional perspectives in the application of medical advances in chronic kidney disease management ” was organized as a forum for sharing and exchanging directions as well as how to apply the results of clinical and research studies. Health economics in the management of chronic kidney disease.
The Inside CKD survey across 11 countries shows that the estimated annual medical costs for chronic kidney disease reach billions of dollars, and account for 2.4 – 7.5% of annual medical spending. Notably, the cost of end-stage chronic kidney disease management for hemodialysis and kidney replacement therapies is particularly high.
Associate Professor, Dr. Dieu Van also said that in reality, early diagnosis and treatment of chronic kidney disease still has many difficulties. As for patients, they do not see clear symptoms in the early stages and do not understand the risk of kidney disease, so most come to the hospital in the late stages.
The rate of disease detected in stage 3 is only 5% of adults with the disease, most of the disease is discovered when it is already in stages 4 and 5 requiring kidney replacement therapy. It is expected that by 2030, 5 million people will need kidney replacement. Therefore, early diagnosis and intervention of chronic kidney disease is very important for the whole society.
At the discussion, medical experts also discussed many different approaches to applying recent medical advances in chronic kidney disease management from early diagnosis to early disease control.
Large clinical trials published around the world on chronic kidney disease control have also been analyzed and evaluated in detail by experts, including the SGLT-2i inhibitor group. The DAPA-CKD study, a global clinical trial investigating the effects of the drug Dapagliflozin in this drug group on patients with chronic kidney disease from different countries including Vietnamese patients, has been published. published and showed a 39% (HR 0.61; 0.51, 0.72; p<0.001) reduction in the risk of disease progression and a 31% (HR 0.69; 0.53, 0.88; p=0.004) reduction in the risk of death in subjects. suffer from this disease .
Experts also acknowledge that, after 20 years, studies such as the DAPA-CKD study have opened up new directions in managing chronic kidney disease from an early stage. Currently, this medicine has been approved by the Vietnam Ministry of Health for use in patients with chronic kidney disease with a prescription from a treating doctor. In addition, solutions to enhance the diagnosis of chronic kidney disease at an early stage with tests with high detection rates were also analyzed at the seminar, including recommendations for consideration of implementation. These solutions from grassroots health levels can help detect and intervene on diseases earlier.
At the discussion, President of the Vietnam Medical Association Nguyen Thi Xuyen emphasized that in recent years, the Ministry of Health has encouraged the implementation and development of clinical research, and at the same time developed national treatment guidelines. Based on research results to improve efficiency and quality of patient care.
To date, Vietnam has become one of the important research destinations, participating in global clinical development programs in many fields with contributions from many subjects to pivotal research, especially with cardiovascular-renal-metabolic diseases in general and chronic kidney disease in particular.
Forrest Bruen